EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models

Gergő Borka, Maurizio Aiello, Silvia Scaglione, Maria Elisabetta Federica Palamà

Frontiers in Bioengineering and Biotechnology · 05.11.2026 · 14

DOI: 10.3389/fbioe.2026.1994581 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 05.11.2026. Verfasst von Gergő Borka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy. Die Arbeit nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced gastrointestinal toxicity (DiGIT) represents a major dose-limiting adverse effect that severely compromises patient outcomes and therapeutic efficacy across global populations. Frequently triggered by chemotherapeutic agents and non-steroidal anti-inflammatory drugs (NSAIDs), DiGIT spans a clinical spectrum from mild dyspepsia to life-threatening complications, including severe mucositis, ulceration, and gastrointestinal (GI) bleeding. Because the GI tract serves as a primary site of drug exposure, its rapidly proliferating epithelial architecture, mucosal immune interface, and complex microbiota, essential components of intestinal homeostasis, are particularly susceptible to off-target therapeutic damage. This review provides a comprehensive analysis of DiGIT across the upper and lower GI tracts, examining the distinct toxicity profiles of NSAIDs and chemotherapy. We detail the underlying pathophysiological mechanisms, focusing on drug-induced epithelial damage, innate immune system activation, and microbiome dysbiosis, alongside current supportive management strategies. Finally, we highlight the preclinical landscape of in vitro toxicity testing, outlining how emerging, physiologically representative bioengineered models can better evaluate GI safety, streamline risk assessment, and improve candidate drug success.

Schlagwörter

Stichwörter der Autor:innen

NSAIDsOOCchemotherapydigitin vitrointestinal toxicityorgan-on-chippreclinical testing

Autor:innen und Institutionen

  • Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
  • React4Life, Genova, Italy.
  • IEIIT-National Research Council (CNR), Genoa, Italy.

Zitieren

APA

Borka, G., Aiello, M., Scaglione, S., & Palamà, M. E. F. (2026). Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1994581

Vancouver

Borka G, Aiello M, Scaglione S, Palamà MEF. Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1994581

BibTeX
@article{Borka2026,
  author = {Borka, Gergő and Aiello, Maurizio and Scaglione, Silvia and Palamà, Maria Elisabetta Federica},
  title = {Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fbioe.2026.1994581}
}
Kostenlos starten →